(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RM

ST13

US500000077297587

Class

35, 36, 42

Filing

77297587

Registration

3533224

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

10/24/2018

Trademark type

Combined

Nice classes

35, 36, 42

Filing date

10/05/2007

Registration date

11/18/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/24/2018

Last transaction

10/24/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

2006-04-00

First use in commerce

2006-04-00

Drawing code

3

Owner type

03

Owner location

Tokyo, JP

Examiner

MCDOWELL, MATTHEW J

Law office

L10

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of "Rm" & design.

Holders and representatives

Holders

ReqMed Company, Ltd.

Representatives

Rebeccah Gan WENDEROTH LLP

Technical classification

Nice Classes

Class 35Class 36Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Clerical services for export and import agencies

Class 36

Equity or research financial investment in the field of pharmaceutical venture companies in the U.S. to facilitate product development

Class 42

Medical testingmedical researchinspection of medicinesproviding medical informationproviding information about medicinesdiagnostic preparations and pre-clinical compounds to assist in licensing-out activities of promising pre-clinical compounds and act as an intermediary between U.S. and Japanese pharmaceutical companies; providing research information on pre-clinical compounds for new drugs; co-development of candidate compounds for new drugs for others; medical and pharmaceutical research and development consulting services

Publications

History of USPTO decisions and trademark events.

26 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/24/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/24/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/24/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

10/22/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/18/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/04/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/04/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/20/2014

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/20/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/20/2014

E815

TEAS SECTION 8 & 15 RECEIVED

11/04/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/13/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

11/18/2008

PUBO

PUBLISHED FOR OPPOSITION

09/02/2008

NPUB

NOTICE OF PUBLICATION

08/13/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/25/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/24/2008

ACEC

AMENDMENT FROM APPLICANT ENTERED

07/18/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/18/2008

ALIE

ASSIGNED TO LIE

07/18/2008

MAIL

PAPER RECEIVED

07/17/2008

CNRT

NON-FINAL ACTION MAILED

01/17/2008

CNRT

NON-FINAL ACTION WRITTEN

01/17/2008

DOCK

ASSIGNED TO EXAMINER

01/13/2008

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

10/13/2007

NWAP

NEW APPLICATION ENTERED

10/12/2007

Continuous trademark protection

Get notified about every new filing that threatens RM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.